Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
248.50    -1.50 (-0.60%)
Bid:
245.00
Ask:
252.00
Spread: 7.00 (2.857%)
Market Cap: £225.74m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

27 Nov 2023 07:00

RNS Number : 6684U
Concurrent Technologies PLC
27 November 2023
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

 

27 November 2023

Concurrent Technologies Plc

(the 'Company')

 

Trading Update

 

Concurrent Technologies Plc (AIM: CNC), a world-leading specialist in the design and manufacture of high-end embedded computer systems and boards for critical applications, is pleased to announce a trading update for the year ended 31 December 2023 ("FY23").

 

Revenue performance of the Company has continued the trend established in the first half of the year, with the Board now expecting to deliver revenue for FY23 ahead of market expectations*, prior to the contribution of Phillips Aerospace which was acquired in September 2023. Revenue for the six months to 31 December 2023 ("H2 2023") is expected to be substantially higher than any prior half-year in the Company's history, driven by the strength of order intake over the preceding 24 months enabled by the significant investment in product development undertaken to facilitate new customers and design wins. Management has worked closely with suppliers and customers to successfully manage the supply chain issues that previously impacted performance and is pleased to report that these factors have continued to ease as the year has progressed.

 

Order intake has continued the strong profile demonstrated in the preceding year, continuing to provide the Board confidence in the delivery of material revenue growth in the year ended 31 December 2024 ("FY24") and beyond.

 

Further evidence of the success of the Company's strategy is in the increasing diversification of its end markets and the increasing value of single orders. These larger orders include a previously announced significant Systems order, as well as a number of larger orders for Single Board Computers with large Defence Primes as the end customer. The refreshed Sales team is core to delivering the Company's strategy and the level of order intake and revenue delivery are evidence of their capability.

 

Additionally, the Company is establishing a track record for excellence in relation to design wins in the relevant sectors. Management categorises a design win as the down selection of a Concurrent Technologies product by a customer, with purchase orders to follow once the customer's end-product reaches main production. Accordingly, once a design win is achieved there is an expectation that there will be multiple years of repeat orders for the relevant product. To date in FY23, the Company has won eight major design wins, outperforming any other year in the Company's history. A major design win is classified as one that is likely to yield more than £1 million in revenue per annum for multiple years and so are anticipated to materially impact revenue performance from 2025 onwards, as production levels scale-up. The anticipated lifetime value of the major design wins secured in FY23 is estimated to be in excess of £100 million, although this amount will be dependent on future programme production rates and is not currently contracted. This change in approach is a function of the investment made in the Company's product development and business development capability. If this can be replicated year on year this will allow the Company to develop a substantial long-term pipeline of revenue opportunities.

 

The Board are pleased to note that profit contribution has strengthened quarter-on-quarter throughout FY23, and it is anticipated that Q4 2023 will be the strongest quarter in an already record-breaking year. To position the business for the future, management have continued to invest in the operational scale of the Company to deliver an increasing level of revenue in the future years. Accordingly, the profit of the Company as a whole in FY23 is expected to be in line with current market expectations**.

 

Following the completion of the acquisition of Phillips Aerospace in September 2023, the Systems division is gearing up to be a core part of this future performance. The Phillips Aerospace business has already been successfully integrated into the Company's operations, with key hires in progress and a number of important process changes being implemented in the governance and control of that business. Specifically, the Board is delighted by the level of motivation and integration that the two prior owner-managers have shown and both have contributed significantly to the technical and managerial community within Concurrent Technologies. Pleasingly, revenue contribution by the Phillips Aerospace business in the short period since the completion of the acquisition is expected to be approximately £500,000, slightly stronger than may have been expected from prior annual performance. The Board expects this to increase significantly as Systems contracts are secured in the future.

 

This increased level of performance across the Company has been delivered despite several larger multi-year orders, for which the Company has already been down selected, moving from the current year into FY24 due to customer timelines, further strengthening the conviction of management in the delivery of further growth in FY24.

 

Chief Executive Officer Miles Adcock said "The performance of the team across the Company has been exceptional throughout the year and, coupled with the continued easing of supply chains, we have seen revenue run rates almost double when compared to historical norms. Our success with design wins provides confidence that order intake moving forward will continue the current level of strong performance which will position us well to enjoy further growth through FY24 and beyond.

 

The Systems business will continue to require focus and investment to deliver substantial growth, but we are developing the capabilities required to secure further Systems contracts in future periods.

 

Our exciting and evolving business is delivered by brilliant people. So far this year we have increased headcount by another 10% as we grow. Attracting and retaining talent is core to our strategy, and I am delighted that we were recently awarded Gold status by the 5% Club; recognising that more than 5% of our workforce is engaged in 'earn & learn' learning programmes."

 

Note that the Company will issue a post-close trading update in early January 2024.

 

*Consensus revenue expectations for 2023 are £27m

**Consensus profit before tax expectations for 2023 are £3.5m

 

Enquiries:

Concurrent Technologies Plc

Miles Adcock, CEO +44 (0)1206 752626

Kim Garrod, CFO

 

SEC Newgate (Financial PR)

Bob Huxford +44 (0)20 3757 6880

Alice Cho +44 (0)20 3763 3342

Matthew Elliott concurrent@secnewgate.co.uk

 

Cavendish Capital Markets Limited (NOMAD and Broker)

Neil McDonald +44 (0)131 220 9771

Peter Lynch +44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core? processors, Intel® Xeon® and Intel Atom? processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVVUROOUAUUA
Date   Source Headline
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement
9th Dec 20114:53 pmRNSProduct Launch
2nd Dec 201111:03 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.